We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nearly half a million Americans are diagnosed with ...

The toxins TcdA (toxin A) and TcdB (toxin B) are the critical virulence factors leading to the intestinal damage and inflammation that characterize C. difficile infection. Binding to epithelial cells ...

Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100% vaccine efficacy Median CDI duration was 1 versus ...

The bacterium Clostridioides difficile causes about 500,000 infections in the US each year, according to the US Centers for Disease Control and Prevention. These infections inflame the colon, cause ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

– Data from Phase 3 open-label single-arm study of VOWST found nearly 95% of individuals with a clinical response at 8 weeks remained free of CDI through Week 24, regardless of number of prior C.

Clostridioides difficile (C. difficile or C. diff) is a type of bacteria that causes a range of gastrointestinal symptoms, from mild diarrhoea to life-threatening colitis. It affects the colon, which ...

Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...

Attendees at the Society for Healthcare Epidemiology of America (SHEA) 2023 Spring Conference heard presentations about using electronic health records to identify cases of Clostridioides difficile ...